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h Abstract
Objective. To determine whether a quality assurance
(QA) program using digital cervicography improved the per-
formanceofa visual inspectionwithacetic acid (VIA) todetect
cervical intraepithelial neoplasia grade 2 or worse (CIN 2+) in
HIV-infected women in Johannesburg, South Africa.
Materials and Methods. Visual inspection with acetic
acid was performed among HIV-infected women, aged 18
to 65 years, in Johannesburg, South Africa. Nurses received
2 weeks of training on the VIA procedure. The VIA inter-
pretation was performed in real time. The VIA results were
then photographed using a retail available digital camera.
A gynecologist and medical officer reviewed the VIA dig-
ital images within 2 weeks of the procedure. Colposcopic
biopsy was performed on all women with positive VIA and
25%negativeVIA results. Sensitivityand specificity ofVIA for
the detection of CIN 2+ were compared between the nurses
and physicians at the beginning and at the end of the study.
Results. Positive VIA results were found in 541 (45%)
of the 1,202 participating women. The sensitivity of VIA to
predict CIN 2+ was improved from 65% to 75% (p = .001)
with the addition of digital cervicography and specialist
review. There was no statistical difference in the sensitivity
of the VIA readings when comparing the first 600 partici-
pants to the final 593 participants between the nurses
(p = .613) and physicians (p = .624).
Conclusions. Quality assurance performed by specialists
using digital cervicography improved the sensitivity of VIA.
There was no difference in sensitivity in interpreting VIA
between the beginning and the end of the study. Quality
assurance should form a cornerstone of any VIA program to
improve sensitivity in detecting CIN 2+ lesions. h
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Cervical cancer is a leading cause of cancer deathamong women in sub-Saharan Africa [1]. Access to
cytology-based screening programs is limited in many
African countries owing to the lack of skills, capacity,
financial resources, and the inability of women to return
for results because of several reasons such as limited
transport, work, and childcare issues. Visual inspection
with acetic acid (VIA) has been suggested as an alter-
native method of screening for cervical disease and has
similar sensitivity to Pap smears for the detection of high-
grade cervical lesions in HIV-infected women [2Y4]. Sev-
eral resource-limited countries are expanding cervical
cancer screening using the VIA screening method [5]. A
quality assurance (QA) program is crucial to the suc-
cessful implementation of a cervical cancer screening
program. However, data evaluating the effect of QA
programs in improving the sensitivity of VIA for the
diagnosis of cervical intraepithelial neoplasia 2 or worse
(CIN 2+), in HIV-infected women, is limited. We present
the results of an evaluation of a QA program for VIA,
which was nested within a large screening study com-
paring human papillomavirus (HPV), cytology, and VIA
performed in 1,202 HIV-infected women in South Africa
[2]. In addition, we evaluated the level of improved skill
among nurses and specialists in correctly interpreting VIA
as an indicator for CIN 2+ during the course of the study.
METHODS
Study Procedures
In the parent screening study, a total of 1,202 women
were recruited and enrolled between November 2009
and August 2011 in an HIV clinic located in a tertiary
hospital in Johannesburg, South Africa [2]. Women were
screened with Digene Hybrid Capture 2 High-Risk HPV
DNA Test (Qiagen GmbH, Hilden, Germany), a con-
ventional Pap smear, and VIA. Experienced South African
primary health care nurses were trained to perform VIA
for 2 weeks at the Cervical Cancer Prevention Program in
ZambiaVa large PEPFAR-funded VIA + television (TV)
monitor-linked digital cervicography screening program,
in operation since 2006, that is linked to HIV care and
treatment with both theoretical and practical hands-on
skills training developed and supervised by professor
Groesbeck Parham [6]. Training and study implemen-
tation were conducted in accordance with the standard
operating procedures of the Cervical Cancer Prevention
Program in Zambia. Visual inspection with acetic acid
was conducted by applying 5% acetic acid to the cervix
and waiting for 3 minutes [7, 8]. Visual inspection with
acetic acid was then interpreted by the study nurse in
real time without the aid of digital cervicography, and
results were recorded. A digital photograph was then
taken using a PowerShot A590 IS 8-megapixel (3264 
2448) camera (Canon, Chiba, Japan) with LA-DC52G
lens adaptor (Canon) and 250D close-up lens digital
camera (Canon) available at retail level in South Africa.
Digital images were stored electronically on a laptop
computer under the confidential patient identifier assigned
by the study, backed-up on an external hard drive, and
stored on an institutional server. In addition, all VIA
results were also recorded manually as a picture drawn
in the patient’s paper file.
All photographs were reviewed within 2 weeks of the
VIA procedure at a weekly QA meeting attended by the
study team. The digital photographs were placed on a
computer and projected onto a screen for visual inter-
pretation by the study physicians. Two physicians re-
viewed the images; 1 physician per protocol was required
to be a registered gynecologist registered by the Health
Professions Council of South Africa. The other physician
was a medical officer trained and active in colposcopic
interpretation and biopsy. The VIA real time (nurse) and
digital review (physician) interpretations of VIA were
then compared. All medical staff were blinded to Pap
smear and HPV results at the time of interpreting the
digital image.
To evaluate whether VIA interpretation improved
with experience of reading VIA, the first 300 VIA
study readings were compared with the last 300 VIA
results and, in addition, a comparison of the first 600
VIA readings versus the last 593 VIA readings for
CIN 2+ was conducted for approximately 18 months.
Similar analyses were also undertaken for the digital
images, and interpretation was performed by the study
physicians.
All women with a positive VIA or abnormal Pap
smear result were referred for a confirmatory colpos-
copy and biopsy. Approximately 25% of women with
negative VIA results and negative Pap smear also re-
ceived a colposcopic biopsy at the 6- and 12-o’clock
positions of the cervix to adjust for verification bias [9].
The HPV results in the parent study were for research
purposes only and were not used for clinical decisions
for treatment. The protocol was approved by the Human
Research Ethics Committee (Medical) of the University
of Witwatersrand and, for secondary data analyses,
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by the Institutional Review Board of the University of
North Carolina.
Statistical Analyses
Sensitivity and specificity estimates for VIA interpreta-
tion for the detection of CIN 2+ were estimated using
maximum likelihood estimators [9]. Sensitivity and spec-
ificity for VIA interpretation for physicians and nurses
were then compared using a J statistic. Positive predic-
tive values and negative predictive values were calcu-
lated; 95% confidence intervals (CIs) were derived from
the asymptotic normalities of maximum likelihood es-
timators and their asymptotic variances.
RESULTS
The parent screening study recruited 1,202 women, of
whom 1,193 were evaluable. Nine women were excluded
from the analysis because they did not have a complete set
of results (6 had inadequate or no cytology and 3 had
invalid HPV or VIA results). The median age and CD4
count were 38 years (interquartile range [IQR] = 32Y43 y)
and 394 cells/mm3 (IQR = 252.5Y572 cells/mm3), re-
spectively. Overall, 528 (45%) of the women had posi-
tive VIA results on final review. There was a higher
number (n = 872, 73%) of abnormal cytology results.
Almost half of the abnormal Pap smear results (n = 399)
were high-grade lesions. Confirmative colposcopic bi-
opsy was obtained from 94.4% (878/930) of the women
requiring biopsy per the study protocol. There were 2
histologically diagnosed cases of invasive cervical car-
cinoma. A discrepancy was found between cytology and
histology in 14% of cases. Only 3% (2/63) of the veri-
fication biopsies showed histologic results of CIN 2 cases.
Histologic review of the follow-up loop electrical exci-
sion procedure results for these 2 CIN 2 cases revealed no
high-grade cervical precancer and only minimal changes
consistent with the presence of HPV infection [2].
There was substantial agreement between the VIA
real-time readings of the nurse and that of the physician
with digital cervicography (J statistic = 0.69, 95% CI =
0.64Y0.73). Nurses achieved a sensitivity of 65.4%
(95% CI = 59.7%Y71.1%) with real-time VIA inter-
pretation; however, the sensitivity achieved through the
physician’s/specialist physician’s review using digital
cervicography secondary review was notably higher
(75.5%, p = .001). The specificity for CIN 2+ between
the nurses and the physicians was similar at 68% (see
Table 1). By comparing the VIA interpretations to detect
CIN 2+ at the beginning of the study to the end of the
study, it was observed that there was no statistical dif-
ference between the ability of nurses or physicians to
detect CIN 2+ at the beginning and at the end of the
study (see Figure 1).
DISCUSSION
At present, there are few published studies on the re-
quirements and/or benefits of QA within a VIA screen-
ing program in HIV-infected women in resource-limited
countries where this type of program is most likely to be
implemented. Digital cervicography has been proposed
as a valuable adjunctive procedure to VIA in improving
diagnostic capability, and it can also be used in QA and
teaching within a VIA screening program [6Y8]. Our QA
program with initial VIA readings followed by expert
review using digital cervicography showed a higher sen-
sitivity in detecting CIN 2+ similar to results from a study
conducted among the general population of women in
Northeast Brazil (mean age = 27.6 y) [10].
Although digital cervicography may seem incon-
gruous for resource-limited countries because of addi-
tional technical equipment, costs, and increased personnel
requirements, QA programs have been successfully
implemented in Zambia [6, 7] and in rural South Africa
(Dr Bridgette Goeieman, personal communication). These
2 programs involve a review of digital photographs that
are brought to the specialist physicians trained in col-
poscopy. Both programs are successfully based on com-
mercially available digital cameras and images that are
stored on laptop computers and transferred to experts
for review through a multitude of reasonably afford-
able technology such as e-mail zip files or mobile phone
technology. If the Internet is not available, we have
downloaded the images to USB/memory sticks, and these
have been couriered to the specialists for their review.
In addition, if projectors and/or monitors are not avail-
able, the review can also occur by viewing the image
available on the digital camera itself. The Zambian pro-
gram has termed this electronic cervical cancer control or
‘‘eC3’’ [11]. While there are always problems and hurdles
Table 1. Sensitivity and Specificity for VIA to Determine
CIN 2+
Nurse/VIA real time Physician/digital cervicography p
Sensitivity (%) 65.4 (59.7Y71.1) 75.5 (70.5Y80.4) .001
Specificity (%) 68.5 (65.3Y71.7) 68.1 (65.0Y71.3) .860
Table shows the sensitivity and specificity of detecting cervical intraepithelial neoplasia
grade 2 or worse (CIN 2+) by real-time interpretation of visual inspection with acetic acid
(VIA) of the cervix by the nurses compared to digital cervicography reading by specialist
physicians in Johannesburg, South Africa, from 2009 to 2012.
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such as equipment costs, technical failure, additional
personal time, and training of staff, this system has been
able to successfully screen more than 145,000 women in
Zambia using VIA with digital cervicography using a
digital camera linked to a TV monitor (professor Groesbeck
Parham, personal communication).
Human papillomavirus testingY, histology-, and
cytology-based screening programs throughout the world
are required to have both internal and external QA to
ensure the best screening outcomes for women. For ex-
ample, the cytology-based program in Johannesburg has
both internal and external QA modalities. Internal QA
involves the examination of positive results (atypical
squamous cells of undetermined significance and worse)
by 2 cytotechnologists (one of whom is a senior cyto-
technologist or a physician), 100% rapid review of all
reportedly negative Pap smears, retrospective review in
the case of previous and current Pap smears that have
different diagnoses, and cytologic-histologic correlation.
External QA includes proficiency testing using the Royal
College of Pathologists of Australasia’s QA program for
cytology. A QA program should be required for VIA-
based screening programs.
Another interesting finding of this substudy was that
there seemed to be no difference in the ability to deter-
mine CIN 2+ at the beginning and at the end of the
study for both nurses and physicians. These results sug-
gest that VIA may be learned by qualified nursing staff
within a 2-week rigorous training course, with consistent
readings over time, but that a QA program does not
improve the interpretative skill of clinicians over time. A
2-week training course allows for a reasonable training
implementation time within a country’s cervical cancer
screening program where staffing and funds for training
are often limited. A review of the Alliance for Cervical
Cancer Prevention training program showed that trainees
looking at digital cervical images agreed with an expert
assessment greater than 60% of the time after approxi-
mately 10 days of training [12]. This review also showed
that the level of agreement between different experts
looking at a set of static photographs of cervices had a
J value of 0.57 or overall agreement of 67% [13]. Our
study team, working together, had a higher J score.
This is the first study to report data indicating that a
QA system seems to notably improve the sensitivity of a
VIA screening program in HIV-infected women in sub-
Saharan Africa. In this substudy, it is difficult to deter-
mine whether the improved sensitivity was due to (1) the
digital cervicography, (2) the specialist’s review, (3) the
second review, or (4) the combination of all these spe-
cific interventions. Reviewing the digital photographs is
a quick process that can easily be incorporated into a
routine staff meeting.
The cost of implementing a QA program using a
digital camera (US$ 800), a TV monitor (US$ 300), and
a laptop computer (US$ 1,000) pales in comparison
to the cost of treatment of 1 cervical cancer case, which
involves highly trained physicists, radiation oncologists,
Figure 1. Comparison of visual inspection with acetic acid (VIA) of the cervix for both nurses and physicians in Johannesburg, South
Africa, during the study period from 2009 to 2012.
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gynecologist surgeons, oncologists, cisplatin, and pur-
chase and continual maintenance and calibration of
expensive radiation machines. Access to this necessary
equipment and the expertise to treat invasive cervical
cancer are extremely limited in sub-Saharan Africa. The
process of a second review using digital cervicography
showed an additional 10 women with CIN 2+ (of every
100 women screened) whose disease could be treated
early and cervical cancer could be prevented. The cost
and time to implement a QA program for VIA screen-
ing are well worth the resources required to prevent
cervical cancer.
Implementation of a wide-scale cervical cancer screen-
ing program in sub-Saharan Africa using HPV testing,
VIA with digital cervicography, or cytology will not
occur overnight and will take significant engagement
and political will of the government, health care pro-
viders, and funders to improve access.
The most important take-home lesson is that QA
programs are needed for any screening modality. This
study shows that a QA program involving a second re-
view with digital photographs improves the sensitivity of
the VIA procedure. With the VIA method now being
implemented in many African countries, a well-developed
QA program is imperative to ensure the most successful
screening outcome for the individual woman and the
program as a whole.
Acknowledgments
The study team would like to thank Prof Groesbeck Parham
for his advice, training, and mentorship within this study and
for the implementation of the cervical cancer VIA screening
program. The study team to would also like to thank Andrea
Teagle for help in preparing the tables for this article.
REFERENCES
1. Availableat:http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.
Accessed December 19, 2013.
2. Firnhaber C, Mayisela N, Mao L, Williams S, Swarts A,
Faesen M, et al. Validation of cervical cancer screening methods
in HIV positive women from Johannesburg, South Africa. PLoS
One 2013;8:e53494.
3. Akinwuntan AL, Adesina OA, Okolo CA, Oluwasola
OA, Oladokun A, Ifemeje AA, et al. Correlation of cervical
cytology and visual inspection with acetic acid in HIV-positive
women. J Obstet Gynaecol 2008;28:638Y41.
4. Mabeya H, Khozaim K, Liu T, Orango O, Chumba D,
Pisharodi L, et al. Comparison of conventional cervical cytol-
ogy versus visual inspection with acetic acid (VIA) among HIV-
infected women in western Kenya. J Low Genit Tract Dis
2012;16:92Y7.
5. Pink Ribbon Red Ribbon. 2012 Annual Report:
Partnering for Progress and Purpose. Pink Ribbon Red Ribbon;
2012:6Y8.
6. Cervical Cancer Prevention Program in Zambia. Avail-
able at: http://www.acewcc.org/. Accessed September 30, 2013.
7. Mwanahamuntu M, Sahasrabuddhe V, Kapambwe S,
Pfaendler KS, Chibwesha C, Mkumba G, et al. Advancing
cervical cancer prevention initiatives in resource-constrained
settings: insights from the Cervical Cancer Prevention Program
in Zambia. PLoS Med 2011;8:e1001032.
8. Mwanahamuntu M, Sahasrabuddhe V, Pfaendler KS,
Mudenda V, Hicks ML, Vermund SH, et al. Implementation of
‘see-and-treat’ cervical cancer prevention services linked to
HIV care in Zambia. AIDS 2009;23:N1Y5.
9. Zhou XH, Higgs RE. Assessing the relative accuracies
of two screening tests in the presence of verification bias. Stat
Med 2000;19:1697Y705.
10. Bomfim-Hyppólito S, Franco ES, Franco RG, de
Albuquerque CM, Nunes GC. Cervicography as an adjunctive
test to visual inspection with acetic acid in cervical cancer
detection screening. Int J Gynaecol Obstet 2006;92:58Y63.
11. Parham GP, Mwanahamuntu MH, Pfaendler KS,
Sahasrabuddhe VV, Myung D, Mkumba G, et al. eC3Va
modern telecommunications matrix for cervical cancer pre-
vention in Zambia. J Low Genit Tract Dis 2010;14:167Y73.
12. Blumenthal PD, Lauterbach M, Sellors JW,
Sankaranarayanan R. Training for cervical cancer prevention
programs in low-resource settings: focus on visual inspection
with acetic acid and cryotherapy. Int J Gynaeco Obstet 2005;
89(suppl 2):S30Y7.
13. Sellors JW, Jeronimo J, Sankaranarayanan R, Wright
TC, Howard M, Blumenthal PD. Assessment of the cervix after
acetic acid wash: inter-rater agreement using photographs.
Obstet Gynecol 2002;99:635Y40.
Quality Assurance of Visual Inspection of Cervix & 11
